Nadine M. Tung, Fengmin Zhao, Angela DeMichele, Aleix Prat, Eric P. Winer, Jean Wright, Abram Recht, Anna Weiss, Judy A. Tjoe, Sheldon M. Feldman, Gabrielle Betty Rocque, Mary Lou Smith, Ciara Catherine O'Sullivan, Sagar D. Sardesai, Patricia Villagrasa, Sunil S. Badve, Ann H. Partridge, Kathy Miller, Lisa A. Carey, Antonio C. Wolff. "Predicting pathologic complete response (pCR) from clinicopathologic variables and HER2DX genomic test in stage II/III HER2+ breast cancer treated with taxane, trastuzumab, and pertuzumab (THP): Secondary results from the EA1181/CompassHER2 pCR trial.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.501